Aequus Pharmaceuticals (TSXV:AQS) Net Change in Cash : C$-0.17 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Aequus Pharmaceuticals's Net Change in Cash for the three months ended in Dec. 2024 was C$-0.02 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.17 Mil.

Aequus Pharmaceuticals Net Change in Cash Historical Data

The historical data trend for Aequus Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Net Change in Cash Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

1.24

0.72

-2.14

-0.08

-0.12

Aequus Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															0.06	0.07	-0.20	-0.02	-0.02

Aequus Pharmaceuticals Net Change in Cash Calculation

Aequus Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.656	+	0.045	+	1.491	+	0
	=	-0.12

Aequus Pharmaceuticals's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.079 + 0 + 0.059 + 0

= -0.02

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aequus Pharmaceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (TSXV:AQS) » Definitions » Net Change in Cash

Comparable Companies

XCNQ:JOLT XCNQ:MYCO TSX:WLLW XCNQ:CNTR XCNQ:STKT XCNQ:PLCN XCNQ:VIBE XCNQ:GHG XCNQ:XCX XCNQ:LOWL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

AQSZF:USA AEQ:Germany

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Executives

Doug Janzen Director, Senior Officer

Aequus Pharmaceuticals Headlines

No Headlines